168 related articles for article (PubMed ID: 25981891)
21. Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.
Abedin S; Yanik GA; Braun T; Pawarode A; Magenau J; Goldstein SC; Levine JE; Kitko CL; Couriel DR
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1127-31. PubMed ID: 25687798
[TBL] [Abstract][Full Text] [Related]
22. Multiple breath washout in pediatric patients after lung transplantation.
Nyilas S; Carlens J; Price T; Singer F; Müller C; Hansen G; Warnecke G; Latzin P; Schwerk N
Am J Transplant; 2018 Jan; 18(1):145-153. PubMed ID: 28719135
[TBL] [Abstract][Full Text] [Related]
23. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
24. Soluble CD30 measured after lung transplantation does not predict bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen.
Kwakkel-van Erp JM; Otten HG; Paantjens AW; van Kessel DA; van Ginkel WG; van den Bosch JM; van de Graaf EA
J Heart Lung Transplant; 2008 Oct; 27(10):1172-5. PubMed ID: 18926413
[TBL] [Abstract][Full Text] [Related]
25. Proteomic bronchiolitis obliterans syndrome risk monitoring in lung transplant recipients.
Wolf T; Oumeraci T; Gottlieb J; Pich A; Brors B; Eils R; Haverich A; Schlegelberger B; Welte T; Zapatka M; von Neuhoff N
Transplantation; 2011 Aug; 92(4):477-85. PubMed ID: 21716170
[TBL] [Abstract][Full Text] [Related]
26. Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation.
Walter JN; Fan LL; Bag R; Zhang H; Doan M; Mallory GB; Elidemir O
Transplantation; 2006 Sep; 82(5):709-11. PubMed ID: 16969297
[TBL] [Abstract][Full Text] [Related]
27. Bronchiolitis obliterans syndrome in lung transplant recipients: can thin-section CT findings predict disease before its clinical appearance?
Konen E; Gutierrez C; Chaparro C; Murray CP; Chung T; Crossin J; Hutcheon MA; Paul NS; Weisbrod GL
Radiology; 2004 May; 231(2):467-73. PubMed ID: 15128992
[TBL] [Abstract][Full Text] [Related]
28. Single lung transplantation for chronic obstructive pulmonary disease: pulmonary function and impact of bronchiolitis obliterans syndrome.
Bjørtuft O; Geiran OR; Fjeld J; Skovlund E; Johansen B; Boe J
Respir Med; 1996 Oct; 90(9):553-9. PubMed ID: 8984530
[TBL] [Abstract][Full Text] [Related]
29. Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation.
Nyilas S; Baumeler L; Tamm M; Halter JP; Savic S; Korten I; Meyer A; Singer F; Passweg JR; Latzin P; Stolz D
Chest; 2018 Jul; 154(1):157-168. PubMed ID: 29275133
[TBL] [Abstract][Full Text] [Related]
30. Are we near to an effective drug treatment for bronchiolitis obliterans?
Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
[TBL] [Abstract][Full Text] [Related]
31. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
32. Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation.
Robinson PD; Spencer H; Aurora P
J Heart Lung Transplant; 2015 Aug; 34(8):1082-8. PubMed ID: 25979626
[TBL] [Abstract][Full Text] [Related]
33. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
[TBL] [Abstract][Full Text] [Related]
34. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J
Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692
[TBL] [Abstract][Full Text] [Related]
35. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey.
Kapila A; Baz MA; Valentine VG; Bhorade SM;
J Heart Lung Transplant; 2015 Jan; 34(1):65-74. PubMed ID: 25447585
[TBL] [Abstract][Full Text] [Related]
36. Bronchiolitis obliterans syndrome in lung transplant recipients: correlation of computed tomography findings with bronchiolitis obliterans syndrome stage.
Choi YW; Rossi SE; Palmer SM; DeLong D; Erasmus JJ; McAdams HP
J Thorac Imaging; 2003 Apr; 18(2):72-9. PubMed ID: 12700480
[TBL] [Abstract][Full Text] [Related]
37. Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome.
Fakhro M; Broberg E; Algotsson L; Hansson L; Koul B; Gustafsson R; Wierup P; Ingemansson R; Lindstedt S
J Cardiothorac Surg; 2017 Nov; 12(1):100. PubMed ID: 29178919
[TBL] [Abstract][Full Text] [Related]
38. Conventional high-resolution CT versus contiguous multidetector CT in the detection of bronchiolitis obliterans syndrome in lung transplant recipients.
Dodd JD; de Jong PA; Levy RD; Coxson HO; Mayo JR
J Thorac Imaging; 2008 Nov; 23(4):235-43. PubMed ID: 19204467
[TBL] [Abstract][Full Text] [Related]
39. Endothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipients.
Salama M; Jaksch P; Andrukhova O; Taghavi S; Klepetko W; Aharinejad S
J Thorac Cardiovasc Surg; 2010 Dec; 140(6):1422-7. PubMed ID: 21078427
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients.
Belperio JA; DiGiovine B; Keane MP; Burdick MD; Ying Xue Y; Ross DJ; Lynch JP; Kunkel SL; Strieter RM
Transplantation; 2002 Feb; 73(4):591-9. PubMed ID: 11889437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
